Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 6Breast 2Genitourinary 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 5Breast Neoplasms 3Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Rectal Neoplasms 1Prostatic Neoplasms 1Patient Preference 1Patient Acceptance of Health Care 1Neoplasms, Plasma Cell 1Neoplasms 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Gastrointestinal Neoplasms 1

Interventions

pembrolizumab 36Magnetic Resonance Spectroscopy 23Gemcitabine 19Specimen Handling 15Nivolumab 12Carboplatin 12Surveys and Questionnaires 11Paclitaxel 11Cetuximab 11Early Intervention, Educational 10Bevacizumab 10Standard of Care 9Cyclophosphamide 9Cisplatin 9Radiosurgery 8Methods 8Fluorouracil 8Docetaxel 8Blood Specimen Collection 8Psychiatric Rehabilitation 7Pemetrexed 7sargramostim 6aldesleukin 6Taxes 6Injections 6Fluorodeoxyglucose F18 6Educational Status 6Drug Therapy 6Biopsy 6Albumin-Bound Paclitaxel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Focus Groups × Gastrointestinal × Clear all
NCT02565017 2020-06-25

Examining Patient Preferences About the IBM Watson Oncology Clinical Decision Support System

Memorial Sloan Kettering Cancer Center

Completed
70 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon âš¡